...
首页> 外文期刊>Drug testing and analysis >Optimization and validation of CEDIA drugs of abuse immunoassay tests in serum and urine on an Olympus AU 400
【24h】

Optimization and validation of CEDIA drugs of abuse immunoassay tests in serum and urine on an Olympus AU 400

机译:在Olympus AU 400上进行血清和尿液中CEDIA药物滥用免疫测定测试的优化和验证

获取原文
获取原文并翻译 | 示例
           

摘要

A preliminary initial cloned enzyme donor immunoassay (CEDIA) was optimized for serum and urine drug testing with respect to the German per se limits for driving under the influence of drugs (serum) and lowered cut-offs in cases of driving licence re-granting (urine). The tests were performed on an Olympus AU 400 auto analyzer. Validation revealed sensitivities between 93% and 100% based on comparison with data from gas or liquid chromatography coupled with mass spectrometry. Even if specificity ranged between 83% and 98 %, the tests can be considered useful for forensic purposes. Receiver operating characteristic (ROC) curves, Youden indices, as well as positive and negative predictive values are presented.
机译:相对于德国本身在药物(血清)影响下的驾驶限制,优化了初步的初始克隆酶供体免疫测定法(CEDIA),用于血清和尿液药物测试,并在重新发放驾驶执照的情况下降低了门槛(尿)。测试在Olympus AU 400自动分析仪上进行。根据与气相色谱或液相色谱质谱联用数据的比较,验证显示灵敏度在93%至100%之间。即使特异性在83%到98%之间,也可以将这些测试用于法医目的。给出了接收器工作特性(ROC)曲线,Youden指数以及正负预测值。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号